Skip to main content
Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
11.49
-0.52 (-4.33%)
Oct 31, 2024, 4:00 PM EDT - Market closed

Cogent Biosciences Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
164
Market Cap
1.26B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 20207.87M-14.63M-65.02%
Dec 31, 201922.50M14.14M169.13%
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

COGT News

More News